Vaccines and Immunotherapy for Inflammatory Disease
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Clinical Immunology".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 64
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue focuses on the role of vaccines and immunotherapeutic strategies in preventing and treating inflammatory diseases. Inflammation is a crucial factor in the development of various chronic conditions, including autoimmune disorders, metabolic syndromes, and certain types of cancer. As our understanding of immune regulation improves, new therapeutic vaccines and targeted immunotherapies have emerged as promising tools to address abnormal inflammatory responses.
We invite original research articles, reviews, and clinical studies that examine vaccine-based interventions, immune modulation strategies, biomarkers for vaccine efficacy, and the potential application of immunotherapies in inflammatory disease contexts. We particularly encourage contributions that connect basic immunology with clinical applications.
Dr. Pui-Ying Leong
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- immunotherapy
- inflammation
- autoimmune disease
- cytokines
- immune modulation
- chronic inflammatory diseases
- immune response
- vaccine development
- translational immunology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
